Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to 0.62.

  • 10x Genomics' Asset Utilization Ratio fell 555.51% to 0.62 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.62, marking a year-over-year decrease of 555.51%. This contributed to the annual value of 0.66 for FY2025, which is 115.25% up from last year.
  • As of Q4 2025, 10x Genomics' Asset Utilization Ratio stood at 0.62, which was down 555.51% from 0.64 recorded in Q3 2025.
  • 10x Genomics' 5-year Asset Utilization Ratio high stood at 0.69 for Q1 2025, and its period low was 0.35 during Q1 2021.
  • Over the past 5 years, 10x Genomics' median Asset Utilization Ratio value was 0.59 (recorded in 2023), while the average stood at 0.57.
  • Over the last 5 years, 10x Genomics' Asset Utilization Ratio had its largest YoY gain of 6106.45% in 2021, and its largest YoY loss of 1866.58% in 2021.
  • Quarter analysis of 5 years shows 10x Genomics' Asset Utilization Ratio stood at 0.49 in 2021, then grew by 4.46% to 0.51 in 2022, then rose by 26.79% to 0.65 in 2023, then grew by 1.76% to 0.66 in 2024, then dropped by 5.56% to 0.62 in 2025.
  • Its Asset Utilization Ratio stands at 0.62 for Q4 2025, versus 0.64 for Q3 2025 and 0.68 for Q2 2025.